Viewing nowGlyrile Tablets (Glimepiride)
Glimepiride 2mg
Tablet · Prescription medication
SPC Co., Ltd.

MFDS item code 201301370 · Approved 2013.01.15
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used along with dietary and exercise therapy to help control blood glucose levels in patients with type 2 diabetes. It can be used alone, but when blood glucose control is insufficient, it may be administered in combination with oral hypoglycemics or insulin. Also, if blood glucose control is challenging with sulfonylurea agents or monotherapy with metformin, this drug can be combined with metformin to enhance therapeutic effects. This medication effectively helps improve blood glucose control.
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. Take this medicine once daily. It should be taken before breakfast or immediately before the first main meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, start treatment with glimepiride 1mg once daily. If necessary, increase the dose by 1mg at intervals of 1~2 weeks. In general, doses above 4mg provide little additional benefit, but some patients have achieved better metabolic control by increasing the dose to 6mg (or 8mg). If treatment with 4mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control improves during treatment, the patient's need for this medicine may decrease. Therefore, a dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no precise dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is advisable to follow the method described under Initial dose. That is, start with 1mg daily and adjust the dose at 1~2-week intervals. Consider the efficacy and duration of action of the previous medication. 4) Dose monitoring While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia is promptly controlled by immediate ingestion of sugar. Hypoglycemia may recur after initial successful management during treatment with a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure, and should be used when fasting blood glucose (FBG) exceeds 150mg/dL. Administer 8mg of this medicine once daily with the first meal. Start insulin at a low dose and increase it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. The insulin dose should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glyburide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level can be achieved by adjusting the dose of each medicine. However, efforts should be made to identify the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this medicine and metformin, and the risk may increase. Appropriate precautions should be taken.
This drug should not be used in patients with insulin-dependent diabetes mellitus, diabetic ketoacidosis, or diabetic coma. It should not be administered if there is an allergy to this drug, its components, or sulfonylurea derivatives. Because there is limited experience in patients with severe liver or kidney impairment, switching to insulin therapy is recommended. It is safe to avoid this medication in pregnant women or those who may become pregnant, as well as in nursing mothers. Insulin therapy is recommended for patients with severe infections or before and after surgery and severe trauma, and caution should be exercised in patients with gastrointestinal disorders as there is a risk of hypoglycemia when taking this medication. During the first week of taking this medication, there is a heightened risk of hypoglycemia, so blood glucose levels should be monitored closely. Special caution is required for the elderly, malnourished patients, those with irregular eating patterns, inconsistent exercise and carbohydrate intake, and changes in eating patterns. Patients who frequently consume alcohol, or have decreased kidney and liver function, as well as those with other endocrine disorders, are at higher risk for hypoglycemia and require careful monitoring. Furthermore, if this medication is taken in excessive amounts or in combination with other drugs, the risk of blood sugar fluctuations exists, and consultation with a physician is necessary. This medication lowers blood sugar levels and can cause hypoglycemia, with symptoms including headache, severe hunger, nausea, fatigue, anxiety, confusion, drowsiness, and loss of consciousness. Severe hypoglycemia may lead to seizures or coma, so if symptoms occur, immediate intake of sugar or seeking medical help is required. Additionally, initial administration may lead to temporary visual disturbances, gastrointestinal symptoms, liver dysfunction, blood abnormalities, allergic reactions, etc., so caution is advised. If severe allergic reactions occur, patient should stop taking the medication immediately and inform the healthcare provider. It is important to take this medication regularly along with dietary and exercise regimens and frequently check the blood glucose control status. In case of hypoglycemia, consuming sugar or sugar-containing beverages quickly can relieve symptoms, so it is advisable to always carry sugar with you. Under special circumstances such as stress, surgery, or infection, controlling blood glucose levels may become difficult, so consultation with healthcare professionals is necessary. Also, this medication may affect the ability to drive or operate machinery, so caution is advised. This medication is metabolized in the liver, which may cause interactions with certain other medications. Especially, taking this drug with specific antibiotics, antifungals, anticoagulants, etc., may affect blood glucose control; therefore, patients should inform the healthcare provider of any medications currently being taken. If used with beta-blockers or certain sympatholytics, symptoms of hypoglycemia may be masked, necessitating even more caution. Pregnant women and nursing mothers should receive insulin therapy instead of this medication, as it may affect the fetus or newborn. Safety and efficacy in children and adolescents under 18 years have not been established, so use is not recommended. The elderly may have decreased kidney function, so particular attention should be given to dose adjustment and blood glucose monitoring while taking this medication. In case of overdose, severe hypoglycemia may occur, requiring immediate visit to a medical institution for appropriate treatment. In emergencies, intravenous glucose may be needed to quickly normalize blood sugar levels, followed by continuous monitoring.
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container to prevent exposure to air or moisture. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature.
Dark blue rectangular tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 2mg
Tablet · Prescription medication
SPC Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.